All Resources

Our resource hub to discover reports, policy papers and other forms of informative content

Filter by

Clinical Trials Research Note

In many areas of high unmet patient need, early access to new medicines through clinical trials are the only option for Canadian patients. There are over 3,000 ongoing clinical trials in Canada which provide significant value to patients. Early access to innovative treatments improves health outcomes, increases quality of life, and gives hope to patients and their loved ones. Clinical trials also provide value to our healthcare system, research ecosystem, and economy.

Learn more | View

Cost Drivers Report 2023

Annual cost growth in Canada’s private drug benefit market is driven by increased utilization and chronic disease drugs, with an increase in claimants post‑pandemic.
Read the full report.

Learn more | View

Value of Medicines in Canada

This study examines and quantifies the value of innovative treatments in Canada to patient lives, the healthcare system and to society. Case studies include: HPV vaccines, Melanoma treatments, treatment for Rheumatoid Arthritis and Hepatitis C.

Learn more | View

Cost of A Private Drug Plan Claim

IMC contracted Reformulary Group to analyze the cost of a private plan prescription drug claim in Canada, and separately in Quebec. This report summarizes that analysis.

Learn more | View


Discover. Learn.

Informative content to keep you up to date on the most pressing issues facing our industry.